On September 25, 2024 ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, reported that company management will participate in the following upcoming conferences (Press release, ReCode Therapeutics, SEP 25, 2024, View Source;utm_medium=rss&utm_campaign=recode-therapeutics-to-participate-in-upcoming-investor-conferences-2 [SID1234646861]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Chardan’s 8th Annual Genetic Medicines Conference
Format: Panel, Presentation and 1×1 Investor Meetings
Date: September 30, 2024
Company Presentation Time: 9:00 am – 9:30 am EST
Panel Participation: Next Generation Delivery Strategies at 3:00 pm EST
Location: New York

2024 RBC Capital Markets Biotechnology Private Company Virtual Conference
Format: Presentation and 1×1 Investor Meetings
Date: October 1, 2024
Presentation Time: 11:20 am – 11:50 am EST
Location: Virtual